Rita Matos

6PUBLICATIONS
27CO-AUTHORS
Predictive and prognostic markersMedical bacteriologyCancer therapy (excl. chemotherapy and radiation therapy)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 08, 2023
Syndecan-4 is a maestro of gastric cancer cell invasion and communication that underscores poor survival.

Juliana Poças, Catarina Marques, Catarina Gomes

|Feb 25, 2022
Presence of Helicobacter Species in Gastric Mucosa of Human Patients and Outcome of Helicobacter Eradication Treatment.

Rita Matos, Emily Taillieu, Sofie De Bruyckere

|Dec 30, 2021
Helicobacter species binding to the human gastric mucosa.

Rita Matos, Hugo Santos Sousa, Jorge Nogueiro

|Aug 27, 2021
High Drug Resistance in Feline Mammary Carcinoma Cell Line (FMCm) and Comparison with Human Breast Cancer Cell Line (MCF-7).

Ana Salomé Correia, Rita Matos, Fátima Gärtner

|Jan 07, 2021
Mycobacterium tuberculosis Infection Up-Regulates Sialyl Lewis X Expression in the Lung Epithelium.

Rita Matos, Kaori L Fonseca, Stefan Mereiter

|Jul 08, 2020
Antimicrobial Susceptibility Pattern of Helicobacter heilmannii and Helicobacter ailurogastricus Isolates.

Rita Matos, Chloë De Witte, Annemieke Smet

Pageof 1